Attention Deficit Hyperactivity Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorNantes University Hospital
About this trial
The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged over 18 years
For whom a diagnosis of ADHD has been confirmed less than 12 weeks ago
For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed
Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019)
Disqualifiers
Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible
Presenting difficulties in reading or writing the French language making data collection impossible
Unable to commit to being available for the 2 visits planned as part of the cohort
Under guardianship or legal protection
Trial design
Design model
Single group
Treatments tested in this trial
Patients suffering from the co-occurrence of ADHD and addiction(s)
Other interventionAll eligible patients over 18 years, presenting both a diagnosis of ADHD and a diagnosis of at least one addictive disorder (SUD, AUD (Alcohol Use Disorder) and/ or behavioral addiction), starting care in one of the three participating centers, and meeting the indication for treatment with MPH according to European recommendations (J. J. S. Kooij et al., 2019)
Treatment groups
80 Participants
are divided into 1 treatment groupGroup A: Neuropsychological assessmentOther 1 intervention
Trial outcomes
Primary outcomes
1
Functional impairment
Weiss Functional Impairment Rating Scale (WFIRS-S) (scores of the 7 domains and total score)
Time frame
Inclusion and 12-month follow-upSecondary outcomes
1
Type and severity of ADHD
Diagnostiscal Interview Voor Attention deficit hyperactivity disorder (DIVA-5)
Time frame
Inclusion2
Symptoms of ADHD
Adult ADHD Self-Report Scale Symptom Checklist (ASRS-1.1) (inattention and hyperactivity/impulsivity scores)
Time frame
Inclusion and 12-month follow-up3
Addictive disorders - substance use disorders (including tobacco, alcohol and other substances)
Mini International Neuropsychiatric Interview- Simplified for Diagnostic and Statistical Manual (DSM)-5 (MINI-S)
Time frame
Inclusion and 12-month follow-up4
Addictive disorders - gambling disorder
National Opinion research center DSM Screen for gambling problems (NODS)
Time frame
Inclusion and 12-month follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov